Áõ ·Ê |
¼Õ¹ßÀÇ ³Ã°¨ ¹× Àú¸²À» µ¿¹ÝÇÑ ´ç´¢º´È¯ÀÚ Áõ·Ê |
ȯÀÚ ³ªÀÌ/¼ºº° |
69¼¼/ ³²ÀÚ |
±âº»Á¤º¸ |
3³âÀü¿¡ Á¦2Çü ´ç´¢º´ Áø´Ü
´ç½Ã ½ÃÇàÇÑ ½Å°æÀüµµ °Ë»ç»ó¿¡¼ peripheral polyneuropathy, axonopathy and myelinopathy¼Ò°ß
|
³»¿øÀÌÀ¯ |
Lt.4th toe¿¡ bullae, Rt. 2nd, 3rd, Lt. 2nd toe¿¡ ulceration »ý°Ü ³»¿ø |
°ú°Å·Â/°¡Á··Â |
´ç´¢º´ ¹× ´Ù¹ß¼º ½Å°æº´Áõ ÀÖÀ½
°¡Á··Â»ó ƯÀÌ»çÇ× ¾øÀ½
|
¼Ò°ß |
½ÄÀü Ç÷´ç 130 ½ÄÈÄ Ç÷´ç 1979
½Å°æÀüµµ°Ë»ç(NCV): peripheral polyneuropathy, axonopathy and myelinopathy
¹ß¸ñ»ó¿ÏÁö¼ö(ABI) : Rt. ABI 1.09 Lt 1.07
|
ȯÀÚÀÇ ÃÖÁ¾º´¸®º¸°í |
|
ó¹æ |
Ç×»ýÁ¦ Åõ¿©( ampicliilin & sulbactam ) (´ç´¢º´¼º Á·ºÎ±Ë¾ç¿¡ ´ëÇØ)
Cilostazol 200mg
Thioctacid 600mg
Vidagliptin 100/ Metformin 1700mg
|
Rationale |
Ç÷´ç Á¶ÀýÀº ÇöÀç Vidagliptin 50mg/ Metformin 850mg bid »ç¿ëÇÏ¸é¼ ´çÈÇ÷»ö¼Ò 6.6 Á¤µµ·Î Á¶Àý ÁßÀ̳ª ÃÖ±Ù ¹ß³¡ºÎÀ§¿¡ À̻󰨰¢ ¹× °¨°¢ ÀúÇÏ·Î ÀÎÇØ ´ç´¢º´¼º Á·ºÎ±Ë¾çÀÌ ¹ß»ýÇÏ¿´À¸¸ç, ÀÌ¿¡ ´ëÇÑ ±Ùº» ¿øÀÎÀ¸·Î´Â ÀÌÀü ½Å°æÀüµµ°Ë»ç»ó º¸¿´´ø ´Ù¹ß¼º ½Å°æº´Áõ »óÅ¿Í, Pulse volume recording°ú ¹ß¸ñ»ó¿ÏÁö¼ö(ABI)´Â Á¤»ó¼Ò°ßÀ̳ª Á·¹è¸Æ¹ÚÃËÁø»ó Ç÷·ù°¡ ¾àÇØÁ® ÀÖ¾î °æ¹ÌÇÑ Ç÷°üº´ÁõÀÌ º¹ÇÕµÈ °ÍÀ¸·Î ¿¹»óµÈ´Ù. µû¶ó¼ Ç÷´çÁ¶Àý°ú ÇÔ²² ±Ë¾ç ¹× °ñ¼ö¿°¿¡ ´ëÇØ Ç×»ýÁ¦ Åõ¿©, ÇÏÁöÀÇ Ç÷°üº´Áõ°ú ½Å°æº´Áõ¿¡ ´ëÇØ cilostazol°ú thioctacid¸¦ Åõ¿©ÇÏ¿´´Ù.
|
Ä¡·á ÈÄ È¯ÀÚÀÇ º¯ÈµÈ
ÀÓ»óÀû °á°ú |
HbA1c 6.6
Á·ºÎ±Ë¾ç È£Àü
|
°æ°úº¸°í |
ÇÏÁöÀÇ Á·ºÎ±Ë¾ç ¹× ¿°ÁõÀº È£Àü ¾ç»óº¸À̸ç, °¨°¢ÀÌ»ó µî¿¡ ´ëÇØ¼µµ È£Àü ÁßÀ¸·Î ¿¹»óÇϸç ÇâÈÄ ÃßÀû PVRÀ̳ª ¸ÆÆÄÀü´Þ¼Óµµ(PWV)ÃøÁ¤ ¿¹Á¤ÀÌ´Ù.
|